X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (735) 735
Conference Proceeding (191) 191
Patent (189) 189
Book Review (88) 88
Publication (77) 77
Book Chapter (10) 10
Book / eBook (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (461) 461
index medicus (332) 332
humans (311) 311
biochemistry (191) 191
chemistry (189) 189
metallurgy (189) 189
beer (188) 188
compositions or test papers therefor (188) 188
condition-responsive control in microbiological orenzymological processes (188) 188
enzymology (188) 188
measuring or testing processes involving enzymes, nucleicacids or microorganisms (188) 188
microbiology (188) 188
mutation or genetic engineering (188) 188
processes of preparing such compositions (188) 188
spirits (188) 188
vinegar (188) 188
wine (188) 188
female (172) 172
male (169) 169
middle aged (153) 153
aged (142) 142
colorectal neoplasms - drug therapy (122) 122
colorectal cancer (121) 121
adult (120) 120
cancer (104) 104
colorectal neoplasms - pathology (85) 85
colorectal neoplasms - genetics (84) 84
antineoplastic combined chemotherapy protocols - therapeutic use (82) 82
human necessities (82) 82
hygiene (82) 82
medical or veterinary science (82) 82
preparations for medical, dental, or toilet purposes (80) 80
antineoplastic agents - therapeutic use (79) 79
chemotherapy (78) 78
aged, 80 and over (77) 77
article (67) 67
treatment outcome (66) 66
prognosis (64) 64
organic chemistry (58) 58
care and treatment (55) 55
pharmacology & pharmacy (55) 55
disease-free survival (50) 50
expression (50) 50
bevacizumab (49) 49
survival (49) 49
cetuximab (48) 48
metastasis (47) 47
specific therapeutic activity of chemical compounds ormedicinal preparations (47) 47
neoplasm metastasis (45) 45
research (44) 44
tumors (43) 43
1st-line treatment (41) 41
animals (41) 41
clinical trials (40) 40
colorectal-cancer (40) 40
fluorouracil (40) 40
medicine & public health (39) 39
oxaliplatin (39) 39
patients (39) 39
investigating or analysing materials by determining theirchemical or physical properties (38) 38
measuring (38) 38
physics (38) 38
testing (38) 38
camptothecin - analogs & derivatives (37) 37
neoplasms - drug therapy (37) 37
fluorouracil - administration & dosage (35) 35
colon-cancer (34) 34
metastases (34) 34
colorectal carcinoma (32) 32
peptides (32) 32
5-fluorouracil (31) 31
antibodies, monoclonal - therapeutic use (31) 31
antineoplastic agents - pharmacology (31) 31
irinotecan (31) 31
mutation (31) 31
angiogenesis (30) 30
biomarkers (30) 30
genetic aspects (30) 30
growth-factor receptor (30) 30
polymorphism, genetic (30) 30
therapy (30) 30
colorectal neoplasms - mortality (29) 29
neoplasm staging (29) 29
thymidylate synthase (29) 29
drug therapy (28) 28
antibodies, monoclonal, humanized (27) 27
antineoplastic agents - adverse effects (27) 27
biomarkers, tumor - genetics (27) 27
breast-cancer (27) 27
fluorouracil - therapeutic use (27) 27
survival analysis (27) 27
metastatic colorectal-cancer (26) 26
nucleotides (26) 26
polymorphism, single nucleotide (26) 26
cells (25) 25
endothelial growth-factor (25) 25
gene expression (25) 25
nucleosides (25) 25
solid tumors (25) 25
antineoplastic agents - administration & dosage (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 10/2009, Volume 15, Issue 20, pp. 6391 - 6397
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2011, Volume 128, Issue 9, pp. 2038 - 2049
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article